Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid for Restenosis in Hemodialysis Vascular Access
NCT03524846Phase 2Completed
- Sponsor
- National Taiwan University Hospital Hsinchu Branch
- Start
- Apr 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ascorbic acid in hemodialysis vascular access failure, sponsored by National Taiwan University Hospital Hsinchu Branch. Started Apr 2011; status: completed.
02
Drugs
ascorbic acid
03
Conditions
hemodialysis vascular access failure
Beyond the preview
Go deeper on NCT03524846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03524846.